OUR TEAM

Ken Domagalski

Executive Vice President of Drug Product Operations 

Ken DomagalskiKen joined Alcami in March of 2020 as the Executive Vice President of Drug Product Operations overseeing all drug product manufacturing facilities for Alcami. Ken has over 35 years in the pharmaceutical industry, of which 20 years were with Teva Parenteral Medicines and Gensia Sicor. Before Alcami, Ken served in ever-increasing responsibilities for Avista Pharma, including Chief Operations Officer and Active President of the early-stage business group encompassing 5 locations for Cambrex. Ken has served in various executive roles, including Vice President of Quality, Vice President of Operations, and Vice President of Process Engineering & Validation. He has led global organizations with hands-on experience, including validation of systems, equipment, cleaning, product, and processes in support of facility startups and new product introductions. During his tenure at Teva Parenteral Medicines, Ken led and provided significant direction in the build-out of a dedicated high potency facility, a facility for sterile suspensions as well as a facility for the manufacture of sterile emulsions. Ken also led automation efforts for the quality support systems as part of the facility and system design and enhancements. Ken has led numerous successful FDA, EMEA, MCA, and other international cGMP inspections. Ken holds a B.S. in Biology/Life Sciences from Niagara University.